Imagine having a high-tech fire drill for a virus before the fire even starts. This work creates a playbook and digital tools to spot a new disease quickly and decide exactly how to react. It's like building a smarter GPS for health officials so they don't get lost when a new pandemic hits.
Delayed and fragmented responses to pandemics lead to massive economic losses and human costs. Current systems lack standardized data sharing and rapid decision-making tools for unknown pathogens.
A science-based blueprint for decision-making, digital monitoring tools, and a data stewards network for pandemic preparedness.
If you are a private health insurer dealing with unpredictable payout spikes during outbreaks — this project developed advanced analytics and models that project transmission dynamics. This allows for better financial risk forecasting and resource allocation.
If you are a vaccine developer dealing with slow data sharing during a crisis — this project developed tools to increase the availability and sharing of high-quality data streams. This helps speed up the identification of pathogen characteristics for faster product development.
If you are a software provider dealing with fragmented monitoring tools — this project developed digital tools to monitor and plan an efficient response. This provides a science-based blueprint to integrate into commercial health surveillance platforms.
Based on available project data, no pricing or cost information is provided as this is an EU-funded research project.
The project specifically aims to improve the scalability of pandemic response plans through standardized protocols and digital tools across 7 countries.
Based on available project data, there are no specific details regarding IP or licensing agreements for the developed tools.
The project focuses on increasing data readiness and creating a data stewards network to improve the sharing of high-quality data streams.
The project period runs from 2023-01-01 to 2026-12-31, indicating the tools and blueprints will be finalized by the end of 2026.
The consortium is purely academic and research-driven, consisting of 4 universities and 4 research organizations across 7 countries. There is a 0% industry ratio, meaning the outputs are currently theoretical and scientific rather than commercially validated. This suggests a high need for industrial partners to translate these findings into commercial products.
Contact Universiteit Hasselt in Belgium for technical details on the pandemic blueprint.
Contact us to find a commercial partner to bridge the gap between this research and market application.
